Literature DB >> 23657157

Surveillance of antibiotic susceptibility of Enterobacteriaceae isolated from urine samples collected from community patients in a large metropolitan area, 2010-2012.

C S Horner1, N Abberley1, M Denton1, M H Wilcox1.   

Abstract

Antibiotic susceptibilities of large cohorts of Enterobacteriaceae isolated from urine collected in the community are scarce. We report the susceptibilities of Enterobacteriaceae isolated from urine of non-selected community populations in a metropolitan area (Leeds and Bradford, UK) over 2 years. Isolates (n = 6614) were identified as follows: Escherichia coli (n = 5436), Klebsiella spp. (n = 525), Proteus mirabilis (n = 305), and 15 other species (n = 290); 58 isolates were unidentified. Ampicillin resistance was observed in 53% E. coli and 28% P. mirabilis; ≥34% E. coli and P. mirabilis were non-susceptible to trimethoprim compared to 20% Klebsiella spp.; nitrofurantoin resistance was observed in 3% E. coli and 15% Klebsiella spp. The occurrence of extended-spectrum β-lactamases (ESBL) was low (6%), as was non-susceptibility to carbapenems, cefipime and tigecycline (<2%). Further surveillance is required to monitor this level of resistance and additional clinical studies are needed to understand the impact on the outcome of current empirical prescribing decisions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23657157      PMCID: PMC9161230          DOI: 10.1017/S0950268813000988

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  10 in total

1.  Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission.

Authors:  Damien Roux; Clarisse Huy; Isabelle Lolom; Antoine Andremont; Guillaume Arlet; Laurence Armand-Lefevre; Jean-Christophe Lucet
Journal:  Scand J Infect Dis       Date:  2011-11-08

Review 2.  The spread of CTX-M-type extended-spectrum beta-lactamases.

Authors:  G M Rossolini; M M D'Andrea; C Mugnaioli
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

3.  Epidemiology and resistance patterns in urinary pathogens from long-term care facilities and GP populations.

Authors:  E Brabazon; M Carton; G Dornikova; D Bedford
Journal:  Ir Med J       Date:  2012-06

4.  When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data.

Authors:  Sharon Hillier; Joanna Bell; Margaret Heginbothom; Zoë Roberts; Frank Dunstan; Anthony Howard; Brendan Mason; Christopher C Butler
Journal:  J Antimicrob Chemother       Date:  2006-10-24       Impact factor: 5.790

5.  Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.

Authors:  Javier Fernández; Juan Acevedo; Miriam Castro; Orlando Garcia; Carlos Rodríguez de Lope; Daria Roca; Marco Pavesi; Elsa Sola; Leticia Moreira; Anibal Silva; Tiago Seva-Pereira; Francesco Corradi; Jose Mensa; Pere Ginès; Vicente Arroyo
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

Review 6.  The epidemiology of urinary tract infection.

Authors:  Betsy Foxman
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

7.  Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.

Authors:  David M Livermore; Russell Hope; Geraldine Brick; Mark Lillie; Rosy Reynolds
Journal:  J Antimicrob Chemother       Date:  2008-11       Impact factor: 5.790

8.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

9.  Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.

Authors:  Neil Woodford; Alessandra Carattoli; Edi Karisik; Anthony Underwood; Matthew J Ellington; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

10.  A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection.

Authors:  D J Farrell; I Morrissey; D De Rubeis; M Robbins; D Felmingham
Journal:  J Infect       Date:  2003-02       Impact factor: 6.072

  10 in total
  5 in total

1.  Genome sequencing and analysis of the first spontaneous Nanosilver resistant bacterium Proteus mirabilis strain SCDR1.

Authors:  Amr T M Saeb; Khalid A Al-Rubeaan; Mohamed Abouelhoda; Manojkumar Selvaraju; Hamsa T Tayeb
Journal:  Antimicrob Resist Infect Control       Date:  2017-11-23       Impact factor: 4.887

2.  CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014.

Authors:  Cliodna A M McNulty; Donna M Lecky; Li Xu-McCrae; Deborah Nakiboneka-Ssenabulya; Keun-Taik Chung; Tom Nichols; Helen Lucy Thomas; Mike Thomas; Adela Alvarez-Buylla; Kim Turner; Sahida Shabir; Susan Manzoor; Stephen Smith; Linda Crocker; Peter M Hawkey
Journal:  J Antimicrob Chemother       Date:  2018-05-01       Impact factor: 5.790

3.  Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates.

Authors:  Mona Shaaban; Soha Lotfy Elshaer; Ola A Abd El-Rahman
Journal:  BMC Microbiol       Date:  2022-10-11       Impact factor: 4.465

4.  Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.

Authors:  Jann-Tay Wang; Pei-Chen Chen; Shan-Chwen Chang; Yih-Ru Shiau; Hui-Ying Wang; Jui-Fen Lai; I-Wen Huang; Mei-Chen Tan; Tsai-Ling Yang Lauderdale
Journal:  BMC Infect Dis       Date:  2014-09-05       Impact factor: 3.090

5.  A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis.

Authors:  J W S Cattrall; E Asín-Prieto; J Freeman; I F Trocóniz; A Kirby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-07       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.